2024 annual financial data
Citius Oncology 2024 Operating margin
Citius Oncology 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -20,572,747 USD and net income was -21,148,747 USD.
Operating cash flow was 126,353 USD.
Get free Citius Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -20,572,747 USD
- Net income
- -21,148,747 USD
- Operating cash flow
- 126,353 USD